Compliance professionals combating drug diversion at their organizations are under more pressure than ever due to factors such as a raging opioid epidemic, staffing shortages, pandemic burnout, and travel nurses unaware of the healthcare organization’s policies and procedures. In a time where hospital leaders are being asked to do more with fewer resources, leveraging technology is the way forward.
Artificial intelligence is vital to drug diversion monitoring because it can review every medication transaction and surface potential suspicious behavior faster and more accurately than manual methods. Time is of the essence when detecting diversion to reduce risk to patient and workforce safety as well as organizational reputation and finances.
A recent study in the American Journal of Health-System Pharmacy showed that advanced analytics and machine learning detected diversion 160 days earlier than methods not using that technology. Firsthand, Protenus has seen our customers’ diversion detection time drop by 80% or more and they’re able to detect diversion within 90 days of the incident occurring, on average.
It can be difficult to know where to start when creating a diversion program — in this webinar, learn best practices and key elements from experts in the fields of compliance and AI to create a successful program and reduce risk at your organization.
- Best practices for implementing a scalable, proactive risk reduction program
- How AI helps drug diversion prevention teams to monitor up to 100% of medication use transactions while requiring fewer resources
- How AI reduced Protenus customers’ diversion detection time by 80%+
CEO and Co-Founder @Protenus
Nick Culbertson is the CEO of Protenus, the #1 Healthcare Compliance Analytics Platform. Under Nick's leadership, Protenus has been recognized by Gartner as a Cool Vendor in Healthcare Artificial Intelligence, by CB Insights as one of the Most Innovative Digital Health Startups, by Forbes as one of America's Top Startup Employers, and by Modern Healthcare as one of the Best Places to Work in Healthcare. Nick was named one of "Healthcare's Entrepreneurs to Know" by Becker's Hospital Review and received SmartCEO's Executive Management Award. In 2021, Nick was named one of Baltimore's Top 40 under 40 and EY's Entrepreneur of the Year.
Dwight de Vera
VP, Healthcare Intelligence @Inmar Intelligence
Dwight de Vera is VP, Healthcare Intelligence at Inmar. He is previously the founder and CEO of RxTransparent which was acquired by Inmar in 2020. He obtained his Bachelor of Science degree in Supply Chain and Information Systems from the Pennsylvania State University. Dwight is recognized as an expert in healthcare analytics and drug supply chain. He is the recipient of many healthcare and technology industry awards and his work has been featured in several industry publications. Dwight is frequently asked to represent the drug dispensing community at regulatory meetings and industry events specifically focused on drug data standards and the Drug Supply Chain Security Act or DSCSA.
B.S. Pharm @Rxpert Solutions
Theresa “Terri” has been a pharmacist for over 30 years with 15 years of experience in medication safety and drug diversion monitoring. Her background includes work in various clinical roles, as well as leadership roles such as Pharmacy Operations Manager, Medication Safety Officer and Pharmacy Director. She is considered a subject matter expert in drug diversion mitigation and monitoring and has successfully implemented drug diversion programs at healthcare facilities. In addition to her years of experience in hospital pharmacy and involvement in drug diversion mitigation and monitoring, she possesses the ability to see the big picture. She is the host of a podcast, Drug Diversion Insights, and is a recognized speaker on the topic of substance abuse and drug diversion. She founded Rxpert Solutions so that all facilities would have access to her expertise as an alternative to, or to act as a bridge while waiting for, personnel on site to develop the expertise.